IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $27.50 Average PT from Brokerages

IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price objective […]